Huntington's Disease Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dr. Kesari on Neuro-Oncology Some patients do well if given treatments in neoadjuvant
Ashkan Lashkari, MD, shares Dr. Kesari on Neuro-Oncology Some patients do well if given treatments in neoadjuvantat the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Fakih's Talk on Colorectal Cancer Microsatellite instability is an approved biomarker
Ashkan Lashkari, MD, shares Dr. Fakih's Talk on Colorectal Cancer Microsatellite instability is an approved biomarker at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Hurvitzs Study on Breast Cancer Using Tumor-Infiltrating Lymphocytes as a biomarker
Ashkan Lashkari, MD, shares Dr. Hurvitzs Study on Breast Cancer Using Tumor-Infiltrating Lymphocytes as a biomarker at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Reckcamp Overview on Lung Cancer Combine established Immunotherapy w new therapies
Ashkan Lashkari, MD, shares Dr. Reckcamp Overview on Lung Cancer Combine established Immunotherapy with new therapies at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.or'>http://www.moasc.or...</a>... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance
Ashkan Lashkari, MD, shares Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for more in... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Powells Study On RCC & amp; Bladder Tumors Augment treatment responses with good safety signals
Ashkan Lashkari, MD, shares Dr. Powells Study On RCC & Bladder Tumors Augment treatment responses with good safety signals at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

MOASC Overview - Highlights from Presentations A number of speakers talk across different tumor types
Ashkan Lashkari, MD, gives a MOASC Overview - Highlights from Presentations A number of speakers talk across different tumor types at the 2018 Oncology Summit in Huntington Beach, CA Go to: http:/... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Looking Forward to Mature Data on Glioblastoma Updates from Antibody-based trials
Santosh Kesari, MD, explains Looking Forward to Mature Data on Glioblastoma Updates from Antibody-based trials at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for m... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs
Santosh Kesari, MD, explains Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs at the 2018 Oncology Summit in Huntington Beach, CA Go to: ... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy Can have Activity in the Brain Do better at managing toxicities
Santosh Kesari, MD, discusses how Immunotherapy Can have Activity in the Brain Do better at managing toxicities at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> fo... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy in Glioma Study in the neoadjuvant setting
Santosh Kesari, MD, Immunotherapy in Glioma Study in the neoadjuvant setting at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for more information Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Identify Who Can Take Immunotherapy in the First-Line The durability of responses would be much better
Marwan Fakih, MD, explains Identify Who Can Take Immunotherapy in the First-Line The durability of responses would be much better at the 2018 Oncology Summit in Huntington Beach, CA Go to: http:/... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Presented Data has Affected Day-to-Day Practice Has already been affecting MSI-High patients
Marwan Fakih, MD, shares Presented Data has Affected Day-to-Day Practice Has already been affecting MSI-High patients at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.o'>http://www.moasc.o...</a>... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Disappointing Data for Patients without MSI Great responses to checkpoint inhibitors
Marwan Fakih, MD, explains Disappointing Data for Patients without MSI Great responses to checkpoint inhibitors at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for ... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate
Marwan Fakih, MD, explains Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate at the 2018 Oncology Summit in Huntington Beach, CA Go to: <a target='_blank' href='http://www.mo'>http://www.mo...</a>... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts